Dr. Reddy’s Laboratories Launches its Generic Semaglutide Injection in Canada

The launch follows Dr. Reddy’s receipt of the Notice of Compliance (NOC) from Health Canada on April 28th, 2026, marking the company’s readiness to serve Canadian patients Dr. Reddy’s is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada Canada is the first G7 country to grant market authorization for... The post Dr. Reddy’s Laboratories Launches its Generic Semaglutide Injection in Canada appeared first on Montreal Gazette .

Original source: Montreal Gazette